Monocytes Reprogrammed by 4-PBA Potently Contribute to the Resolution of Inflammation and Atherosclerosis
Circulation Research · 27.09.2024 · 135 (8) · 856-872
DOI: 10.1161/circresaha.124.325023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation Research, erschienen am 27.09.2024. Verfasst von Shuo Geng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Virginia Tech, Blacksburg (S.G., R.L., Y.Z., Y.W., B.A.C., K.P., Z.Y., J.H., F.X., L.L.). Hauptthemen laut MEDLINE: Atherosclerosis, Monocytes, Inflammation, Phenylbutyrates. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIA NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Chronic inflammation initiated by inflammatory monocytes underlies the pathogenesis of atherosclerosis. However, approaches that can effectively resolve chronic low-grade inflammation targeting monocytes are not readily available. The small chemical compound 4-phenylbutyric acid (4-PBA) exhibits broad anti-inflammatory effects in reducing atherosclerosis. Selective delivery of 4-PBA reprogrammed monocytes may hold novel potential in providing targeted and precision therapeutics for the treatment of atherosclerosis. METHODS: Systems analyses integrating single-cell RNA sequencing and complementary immunologic approaches characterized key resolving characteristics as well as defining markers of reprogrammed monocytes trained by 4-PBA. Molecular mechanisms responsible for monocyte reprogramming were assessed by integrated biochemical and genetic approaches. The intercellular propagation of homeostasis resolution was evaluated by coculture assays with donor monocytes trained by 4-PBA and recipient naive monocytes. The in vivo effects of monocyte resolution and atherosclerosis prevention by 4-PBA were assessed with the high-fat diet-fed ApoE −/− mouse model with IP 4-PBA administration. Furthermore, the selective efficacy of 4-PBA-trained monocytes was examined by IV transfusion of ex vivo trained monocytes by 4-PBA into recipient high-fat diet-fed ApoE −/− mice. RESULTS: In this study, we found that monocytes can be potently reprogrammed by 4-PBA into an immune-resolving state characterized by reduced adhesion and enhanced expression of anti-inflammatory mediator CD24. Mechanistically, 4-PBA reduced the expression of ICAM-1 (intercellular adhesion molecule 1) via reducing peroxisome stress and attenuating SYK (spleen tyrosine kinase)-mTOR (mammalian target of rapamycin) signaling. Concurrently, 4-PBA enhanced the expression of resolving mediator CD24 through promoting PPARγ (peroxisome proliferator-activated receptor γ) neddylation mediated by TOLLIP (toll-interacting protein). 4-PBA-trained monocytes can effectively propagate anti-inflammation activity to neighboring monocytes through CD24. Our data further demonstrated that 4-PBA-trained monocytes effectively reduce atherosclerosis pathogenesis when administered in vivo. CONCLUSIONS: Our study describes a robust and effective approach to generate resolving monocytes, characterizes novel mechanisms for targeted monocyte reprogramming, and offers a precision therapeutics for atherosclerosis based on delivering reprogrammed resolving monocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Virginia Tech, Blacksburg (S.G., R.L., Y.Z., Y.W., B.A.C., K.P., Z.Y., J.H., F.X., L.L.).
- Department of Biochemistry and Molecular Biology, University of North Carolina at Chappell Hill, NC (L.X., X.C.).
ORCID-Profile: Shuo Geng, Yao Zhang, Yajun Wu, Blake A Caldwell, Ziyue Yi, Liwu Li
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Geng, S., Lu, R., Zhang, Y., Wu, Y., Xie, L., Caldwell, B. A., Pradhan, K., Yi, Z., Hou, J., Xu, F., Chen, X., & Li, L. (2024). Monocytes Reprogrammed by 4-PBA Potently Contribute to the Resolution of Inflammation and Atherosclerosis. Circulation Research, 135(8), 856-872. https://doi.org/10.1161/circresaha.124.325023
Vancouver
Geng S, Lu R, Zhang Y, Wu Y, Xie L, Caldwell BA, et al. Monocytes Reprogrammed by 4-PBA Potently Contribute to the Resolution of Inflammation and Atherosclerosis. Circulation Research. 2024;135(8):856-872. doi:10.1161/circresaha.124.325023
BibTeX
@article{Geng2024,
author = {Geng, Shuo and Lu, Ran and Zhang, Yao and Wu, Yajun and Xie, Ling and Caldwell, Blake A and Pradhan, Kisha and Yi, Ziyue and Hou, Jacqueline and Xu, Feng and Chen, Xian and Li, Liwu},
title = {Monocytes Reprogrammed by 4-PBA Potently Contribute to the Resolution of Inflammation and Atherosclerosis},
journal = {Circulation Research},
year = {2024},
volume = {135},
number = {8},
pages = {856--872},
doi = {10.1161/circresaha.124.325023}
}
EUVIMED